99 research outputs found

    How fast is a snail’s pace? The influences of size and substrate on gastropod speed of locomotion

    Get PDF
    Terrestrial gastropods display monotaxic direct crawling. During locomotion, smooth muscle contraction stimulates a series of pedal waves that move along the ventral surface of the foot. These waves interact with a thin layer of mucus produced by the foot, propelling the animal forward. Although the mechanism by which this process occurs has been well studied, less is known about how morphological or environmental factors affect this process, and ultimately how they may alter the speed of propulsion. In this study, we tested the influences of body size, substrate type, and substrate orientation on crawling speed in the terrestrial snail Cornu aspersum. We found that substrate texture and orientation had a strong effect on speed, whereas snail body size and the presence of a conspecific trail did not. Crawling speed across rough sandpaper was the most striking, showing a clear inversely proportional relationship between the size of abrasive particle and speed. We suggest that this may be the result of substrate attributes interfering with mucus adhesion or mucus production, subsequently affecting locomotion, although gait choice or the frequency and length of each pedal wave may also play a role.PostprintPeer reviewe

    Embedded Protostars in the Dust, Ice, and Gas In Time (DIGIT) Key Program: Continuum SEDs, and an Inventory of Characteristic Far-Infrared Lines from PACS Spectroscopy

    Get PDF
    We present 50-210 um spectral scans of 30 Class 0/I protostellar sources, obtained with Herschel-PACS, and 0.5-1000 um SEDs, as part of the Dust, Ice, and Gas in Time (DIGIT) Key Program. Some sources exhibit up to 75 H2O lines ranging in excitation energy from 100-2000 K, 12 transitions of OH, and CO rotational lines ranging from J=14-13 up to J=40-39. [O I] is detected in all but one source in the entire sample; among the sources with detectable [O I] are two Very Low Luminosity Objects (VeLLOs). The mean 63/145 um [O I] flux ratio is 17.2 +/- 9.2. The [O I] 63 um line correlates with Lbol, but not with the time-averaged outflow rate derived from low-J CO maps. [C II] emission is in general not local to the source. The sample Lbol increased by 1.25 (1.06) and Tbol decreased to 0.96 (0.96) of mean (median) values with the inclusion of the Herschel data. Most CO rotational diagrams are characterized by two optically thin components ( = (0.70 +/- 1.12) x 10^49 total particles). N_CO correlates strongly with Lbol, but neither Trot nor N_CO(warm)/N_CO(hot) correlates with Lbol, suggesting that the total excited gas is related to the current source luminosity, but that the excitation is primarily determined by the physics of the interaction (e.g., UV- heating/shocks). Rotational temperatures for H2O ( = 194 +/- 85 K) and OH ( = 183 +/- 117 K) are generally lower than for CO, and much of the scatter in the observations about the best fit is attributed to differences in excitation conditions and optical depths amongst the detected lines.Comment: 58 pages, 37 figures; accepted to Ap

    Evolutionary aspects of population structure for molecular and quantitative traits in the freshwater snail Radix balthica.

    Get PDF
    Detecting the action of selection in natural populations can be achieved using the QST-FST comparison that relies on the estimation of FST with neutral markers, and QST using quantitative traits potentially under selection. QST higher than FST suggests the action of directional selection and thus potential local adaptation. In this article, we apply the QST-FST comparison to four populations of the hermaphroditic freshwater snail Radix balthica located in a floodplain habitat. In contrast to most studies published so far, we did not detect evidence of directional selection for local optima for any of the traits we measured: QST calculated using three different methods was never higher than FST. A strong inbreeding depression was also detected, indicating that outcrossing is probably predominant over selfing in the studied populations. Our results suggest that in this floodplain habitat, local adaptation of R. balthica populations may be hindered by genetic drift, and possibly altered by uneven gene flow linked to flood frequency

    Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

    Get PDF
    Background: Post-COVID-19 condition (also known as long COVID) is an emerging chronic illness potentially affecting millions of people. We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ivermectin, or fluvoxamine soon after SARS-CoV-2 infection could reduce the risk of long COVID. Methods: We conducted a decentralised, randomised, quadruple-blind, parallel-group, phase 3 trial (COVID-OUT) at six sites in the USA. We included adults aged 30–85 years with overweight or obesity who had COVID-19 symptoms for fewer than 7 days and a documented SARS-CoV-2 positive PCR or antigen test within 3 days before enrolment. Participants were randomly assigned via 2 × 3 parallel factorial randomisation (1:1:1:1:1:1) to receive metformin plus ivermectin, metformin plus fluvoxamine, metformin plus placebo, ivermectin plus placebo, fluvoxamine plus placebo, or placebo plus placebo. Participants, investigators, care providers, and outcomes assessors were masked to study group assignment. The primary outcome was severe COVID-19 by day 14, and those data have been published previously. Because the trial was delivered remotely nationwide, the a priori primary sample was a modified intention-to-treat sample, meaning that participants who did not receive any dose of study treatment were excluded. Long COVID diagnosis by a medical provider was a prespecified, long-term secondary outcome. This trial is complete and is registered with ClinicalTrials.gov, NCT04510194. Findings: Between Dec 30, 2020, and Jan 28, 2022, 6602 people were assessed for eligibility and 1431 were enrolled and randomly assigned. Of 1323 participants who received a dose of study treatment and were included in the modified intention-to-treat population, 1126 consented for long-term follow-up and completed at least one survey after the assessment for long COVID at day 180 (564 received metformin and 562 received matched placebo; a subset of participants in the metformin vs placebo trial were also randomly assigned to receive ivermectin or fluvoxamine). 1074 (95%) of 1126 participants completed at least 9 months of follow-up. 632 (56·1%) of 1126 participants were female and 494 (43·9%) were male; 44 (7·0%) of 632 women were pregnant. The median age was 45 years (IQR 37–54) and median BMI was 29·8 kg/m2 (IQR 27·0–34·2). Overall, 93 (8·3%) of 1126 participants reported receipt of a long COVID diagnosis by day 300. The cumulative incidence of long COVID by day 300 was 6·3% (95% CI 4·2–8·2) in participants who received metformin and 10·4% (7·8–12·9) in those who received identical metformin placebo (hazard ratio [HR] 0·59, 95% CI 0·39–0·89; p=0·012). The metformin beneficial effect was consistent across prespecified subgroups. When metformin was started within 3 days of symptom onset, the HR was 0·37 (95% CI 0·15–0·95). There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo. Interpretation: Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe. Funding: Parsemus Foundation; Rainwater Charitable Foundation; Fast Grants; UnitedHealth Group Foundation; National Institute of Diabetes, Digestive and Kidney Diseases; National Institutes of Health; and National Center for Advancing Translational Sciences

    Transition from no-ELM response to pellet ELM triggering during pedestal build-up - insights from extended MHD simulations

    No full text
    Pellet edge localized mode (ELM) triggering is a well-established scheme for decreasing the time between two successive ELM crashes below its natural value. Reliable ELM pacing has been demonstrated experimentally in several devices, increasing the ELM frequency considerably. However, it was also shown that the frequency cannot be increased arbitrarily due to a so-called lag-time. During this time, after a preceding natural or triggered ELM crash, neither a natural ELM crash occurs nor is it possible to trigger an ELM crash by pellet injection. For this article, pellet ELM triggering simulations are advanced beyond previous studies in two ways. Firstly, realistic E × B and diamagnetic background flows are included. And secondly, the pellet is injected at different stages of the pedestal build-up. This allows us to recover the lag time for the first time in simulations and investigate it in detail. A series of nonlinear extended MHD simulations is performed to investigate the plasma dynamics resulting from an injection at different time points during the pedestal build-up. The experimentally observed lag-time is qualitatively reproduced. In particular, a sharp transition is observed between the regime where no ELMs can be triggered and the regime where pellet injection causes an ELM crash. Via variations of pellet parameters and injection time, the two regimes are studied and compared in detail, revealing pronounced differences in the nonlinear dynamics. The toroidal mode spectrum is significantly broader when an ELM crash is triggered, enhancing the stochasticity and therefore also the losses of thermal energy along magnetic field lines. In the heat fluxes to the divertor targets, pronounced toroidal asymmetries are observed. In the case of high injection velocities leading to deep penetration, the excitation of core modes like the 2/1 neoclassical tearing mode is also observed.Peer ReviewedPostprint (published version
    corecore